skip to Main Content

Our Mission

IBT Bioservices is the contract research division of Integrated BioTherapeutics, Inc. (IBT). IBT Bioservices offers a strong client-oriented research and development service focused on our area of expertise, infectious diseases. The team at IBT Bioservices has extensive experience in antiviral and antibacterial screening and model development.

Our Team

M. Javad Aman, PhD

M. Javad Aman, PhD

PRESIDENT AND CSO

Javad leads IBT and its innovative science programs. He is a distinguished researcher in viral and bacterial diseases with 75+ publications.

Gary Nabors

Gary Nabors, PhD

EVP, CHEIF DEVELOPMENT OFFICER

Gary heads IBT’s product development team to translate its discovery pipeline into practical solutions for infectious diseases.

Rick Holtsberg, PhD

Rick Holtsberg, PhD

VP, Manufacturing & Bioanalytics

Rick leads IBT Bioservices’ assay & protein services group and develops IBT’s biochemical reagent portfolio. See Rick’s publications.

Robin Douglas

Robin Douglas

VP, Programs & Operations

Robin leads IBT Bioservices with its state-of-the-art infectious disease research capabilities and strong customer service focus.

Rajan Adhikari, PhD

Rajan Adhikari, PhD

Associate Director, Bacterial Therapeutics

Rajan investigates bacterial pathogens and leads antibacterial vaccine and therapeutic development programs. See Rajan’s publications.

Hatice Karauzum, PhD

Hatice Karauzum, PhD

Associate Director, Translational Research

Hati investigates bacterial pathogenesis and cellular immune responses. See Hati’s publications.

Agnes Chenine, PhD

Agnes Chenine, PhD

Director, Antiviral Research

Agnes oversees the in vivo studies program for testing new therapies and vaccines in various rodent models. See Agnes’s publications.

Sergey Shulenin, PhD

Sergey Shulenin, PhD

Assistant Director, Protein Chemistry

Sergey works on assay development and protein expression. See Sergey’s publications.

Thomas Kort

Thomas Kort

Principal Scientist

Tom works on protein expression and custom scientific projects. See Tom’s publications.

Haimi Shiferaw

Haimi Shiferaw

Business Development Advisor

Haimi leads IBT Bioservices strategic growth, marketing, and customer management team.

Our Partners

Back To Top
×Close search
Search

IBT Bioservices continues to conduct critical work as an essential business under the State of Maryland’s COVID-19 response directive. We have implemented a risk management plan and are continually monitoring the situation to ensure continuation of research according to public health services recommended best-practices for keeping our employees and the community safe. 

The IBT Bioservices team will continue to deliver high quality products and services for every project. If you have any questions contact us at Services@IBTBioservices.com